» Articles » PMID: 16286616

Bimatoprost-induced Periocular Skin Hyperpigmentation: Histopathological Study

Overview
Journal Arch Ophthalmol
Specialty Ophthalmology
Date 2005 Nov 16
PMID 16286616
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To investigate light microscopic and ultrastructural changes in bimatoprost-induced skin hyperpigmentation.

Methods: Eyelid biopsy specimens from bimatoprost-treated patients and matched controls were examined by light microscopy and transmission electron microscopy. Using an image analyzer, melanin granules were counted on Fontana-Masson-stained sections, and melanosomes were counted on electron micrographs. Immunohistochemical analysis was performed with antibodies against S100 and CD3. Positively labeled cells were counted.

Results: By light microscopy, a marked increase in the number of melanin granules was noted in the bimatoprost-treated specimens. Electron microscopy demonstrated dermal melanocytes with prominent rough endoplasmic reticulum and abundant normal-sized melanosomes in different stages of maturation as compared with control specimens. Furthermore, the keratinocytes of the bimatoprost-treated specimens showed abundant mature melanosomes when compared with controls. Also of note, atypical melanocytes were absent in both specimens. The S100-positive melanocytes were comparable in bimatoprost-treated and control specimens. Few CD3- and CD68-positive cells in the bimatoprost-treated specimens were noted in both groups.

Conclusion: Bimatoprost-induced periocular hyperpigmentation is caused by increased melanogenesis. There was no evidence of melanocyte proliferation or prostaglandin-induced inflammation in the specimens that were examined.

Citing Articles

Adverse events of topical ocular prostaglandin medications for glaucoma treatment: a pharmacovigilance study based on the FAERS database.

Wu S, Huang C, Wang Y, Li X, Zhang S, Chen X Ther Adv Drug Saf. 2024; 15:20420986241285929.

PMID: 39429679 PMC: 11487502. DOI: 10.1177/20420986241285929.


Drug-Induced Pigmentation: A Review.

Tisack A, Mohammad T Drugs. 2024; 84(9):1071-1091.

PMID: 39085684 DOI: 10.1007/s40265-024-02062-z.


Comparative study between efficacy of Excimer light with topical Tacrolimus 0.1% versus excimer light with topical Bimatoprost 0.01% in treatment of facial Vitiligo.

Zaky M, Atallah R, El Abasy N, Elsaie M Arch Dermatol Res. 2024; 316(7):350.

PMID: 38850408 PMC: 11162377. DOI: 10.1007/s00403-024-03054-5.


Laser-Assisted Prostaglandin Analogs in the Treatment of Hypopigmented Scars: A Systematic Review.

Rambhia P, Pagan A, Lal K, Goldberg D J Clin Aesthet Dermatol. 2023; 16(9):28-32.

PMID: 37720195 PMC: 10503939.


The efficacy of bimatoprost ophthalmic solution combined with NB-UVB phototherapy in non-segmental and segmental vitiligo: a single-blind randomized controlled study.

Silpa-Archa N, Likittanasombat S, Apinuntham C, Pruksaeakanan C, Charoenpipatsin N, Chaiyabutr C Sci Rep. 2023; 13(1):6438.

PMID: 37081101 PMC: 10119098. DOI: 10.1038/s41598-023-32591-8.